Collaboration and Licensing Agreements - MorphoSys AG/Incyte Corporation (Details) - USD ($) $ in Thousands		12 Months Ended
	Nov. 03, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Sep. 30, 2023
Collaboration research and licensing agreements
Accounts receivable		$ 11,290	$ 28,997
MorphoSys | Collaboration and License Agreement
Collaboration research and licensing agreements
Deferred revenue		0
MorphoSys | Royalties | Collaboration and License Agreement
Collaboration research and licensing agreements
Proceeds from upfront payment	$ 22,500
Accounts receivable					$ 2,200
Revenue recognized		8,700	$ 7,800	$ 5,900
Non-cash revenue recognized		2,100
Contract asset		$ 2,100
MorphoSys | Milestone | Collaboration and License Agreement
Collaboration research and licensing agreements
Revenue recognized				$ 12,500